leisure time -WSS

leisure time

author：entertainment 2025-10-01 00:59:50 - browse：7198

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Devoted Health’s losses in Medicare Advantage persist

WSS

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

What’s missing from the debate over nursing home staff minimums

Asbestos ban is immediate, but health effects will linger for decades

Why Novartis is going to walk from its acquisition of MorphoSys

leisure time

leisure time

leisure time

After affirmative action ruling, medical educators look to 'holistic review'

A single Democrat is willing to weaken Medicare negotiation power

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Asbestos ban is immediate, but health effects will linger for decades

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

With Wegovy coverage, Medicare patients may face high costs

Medical records are filled with copy

This gene therapy has record $4.25 million price. It's saved children.

How one medical school became remarkably diverse

Padmanee Sharma of MD Anderson at center of lawsuit over credit

knowledge

Top private equity targets in 2023: cardiology, clinical trials, lasers

Asbestos ban is immediate, but health effects will linger for decades

AI gets buy

Bernie brings in new pharma CEOs to talk drug prices

Asbestos ban is immediate, but health effects will linger for decades

Medicare Advantage plans can’t deny care with AI, CMS warns

entertainment

focus

focus

explore